Keywords: Parkinson's disease; Excessive day time sleepiness; Monoamines; MPTP; Modafinil; Neurorestoration; Nocturnal;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: α-syn; alpha-synuclein; CNS; central nervous system; PD; Parkinson disease; CX3CR1; fractalkine receptor; CCR2; C-C chemokine receptor type 2; CCL2; C-C chemokine ligand 2; SNpc; substantia nigra pars compacta; GWAS; genome wide association studies; MHCI
Keywords: AMPA; α-Amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid; AP; action potential; APfreq; AP frequency; ATP; Adenosine triphosphate; [Ca2+]; Calcium concentration; ECD; excitotoxic cell death; FCCP; Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone;
Keywords: AD; Alzheimer's disease; ADP; Alzheimer's disease patient; CDR; Clinical Dementia Rating; DCF; chloromethyl-2,7-dichlorodihydrofluorescein diacetate; ER; endoplasmic reticulum; NP; normal patient; MAM; mitochondrial associated membranes; MMP; mitochondria
Keywords: LC; locus coeruleus; QD; quantum dot; SN; csubstantia nigra pars compacta; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Neuromelanin; Ferritin; Quantum dot; Substantia nigra pars compacta; Locus coeruleus; Quantum biology;
Keywords: 6-OHDA; 6-hydroxydopamine; L-DOPA; L-3,4-dihydroxyphenylalanine; MB; methylene blue; MPP+; 1-methyl-4-phenylpyridinium; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; OD; optical density; p; probenecid; PD; Parkinson's disease; SNpc; substantia nig
Keywords: BDNF; brain-derived neurotrophic factor; DTI; diffusion tensor imaging; fMRI; functional magnetic resonance imaging; GDNF; glial cell line-derived neurotrophic factor; MRI; magnetic resonance imaging; MPTP; 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridin
Keywords: AC; anterior commissure; BEDPOSTX; Bayesian estimation of diffusion parameters obtained using sampling techniques X; BET; brain extraction tool; CI; confidence interval; CON; connectivity; DBS; deep brain stimulation; DF; degrees of freedom; DICOM; digita
Keywords: AD; Alzheimer's disease; DA; dopamine; DAergic; dopaminergic; hMAO-A; human monoamine oxidase A; hMAO-B; human monoamine oxidase B; HRP; horseradish peroxidase; IC50; the half maximal inhibitory concentration; i.p.; intraperitoneal; Ki; inhibition const
Keywords: Parkinson's disease; Sex; Nigrostriatal degeneration; Motor symptoms; Non-motor symptoms; MPTP; 6-OHDA; Estradiol;
Keywords: Aβ; amyloid beta; AβO; Aβ oligomer; ACh; acetylcholine; AChE; acetylcholinesterase; AD; Alzheimer's disease; AGEs; advanced glycation end products; AND; age-related neurological disorder; Bax; Bcl-2-associated X protein; Bcl-2; B-cell lymphoma 2; BDNF;
Keywords: Parkinson's disease; MPTP; marmoset; psychosis; dyskinesia; mianserin;
Keywords: Parkinson's disease; Rodent models; Rodent behaviour; Animal models; Alpha-synuclein; LRRK2; GBA; 6-OHDA; Rotenone; MPTP; FBXO7; ATP13A2; VPS35; Parkin; PINK1; DJ-1;
Keywords: AcH; acetaldehyde; CTIQs; catechol isoquinolines; DA; dopamine; DMDHIQ+; 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion; ISOP; isoproterenol; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPP+; 1-Methyl-4-phenylpyridinium; N-Me-Sal; N-methyl-salsolino
Keywords: Parkinson's disease; Electro-acupuncture; Phmri; Behavioral; Dopamine; APO; apomorphine; BOLD; blood oxygen level dependent; EA; electroacupuncture; fMRI; functional magnetic resonance imaging; GDNF; glial cell derived neurotrophic factor; GPe; global p
Keywords: ÎΨ; Mitochondrial membrane potential; Aβ; Amyloid beta; AD; Alzheimer's disease; AMPA; α-amino-3-hydroxy-5-methylisoxazole-4-propionate; ApoE/D; Apolipoproteins E/D; BBB; Blood brain barrier; GSH; glutathione; HD; Huntington's disease; H2O2; hydrogen
Keywords: Parkinson's disease; Ghrelin; Dementia; AHN; adult hippocampal neurogenesis; AD; Alzheimer's Disease; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMPK; AMP-activated protein kinase; AB; amyloid-β; ATG; autophagy-related; BBB; blood brain
Keywords: OS; oxidative stress; ROS; reactive oxygen species; MG; methylglyoxal; glo 1; glyoxalase-1; glo 2; glyoxalase-2; AGEs; advanced glycation end products; ASD; autism spectrum disorder; GSH; reduced glutathione; cas-3; caspase-3; NeuN; neuronal specific nucl
Keywords: Aβ; beta-amyloid; APOE; apolipoprotein E; APP; amyloid precursor protein; AD; Alzheimer's disease; CRISPR; clustered regularly interspaced short palindromic repeats; DAT; dopamine transporter; ER; estrogen receptor; FAD; familial Alzheimer's disease;
Keywords: Parkinson's disease; L-DOPA-induced dyskinesia; 6-OHDA; MPTP; Animal models; Rodents;
Keywords: PC12 cells; Rat adrenal pheochromocytoma cells; SNCA; α-synuclein; pDNA; plasmid DNA; BBB; blood-brain barrier; GNP; gold nanoparticles; CTS; chitosan; DTPA; 3,3â²-dithiodipropionic acid; NHS; N-hydroxysuccinimide; DTSP; dithiobis-(succinimidyl propio
Keywords: Mitochondria; Ceruloplasmin; Amyloid precursor protein; MPTP; Nrf2; Ferroptosis;
Keywords: Dopaminergic (DA) neurons; Inflammatory mediators; Mast cells; Parkinson's disease; Substantia nigra; Transglutaminase 2; BMMCs; Bone marrow-derived mast cells; DA neurons; Dopaminergic neurons; DAT; dopamine transporter; LTs; Leukotrienes; MAOB; Monoamin
Keywords: Mitochondria; Proteomics; Mass spectrometry; Cancer; 1DE; one-dimensional gel electrophoresis; 2DE; two-dimensional gel electrophoresis; 2D-DIGE; fluorescent two-dimensional difference gel electrophoresis; AP; affinity purification; ACAT1; mitochondrial a
Keywords: AA; Arachidonic acid; AhR; Aryl hydrocarbon receptor; BBB; Blood-brain barrier; cDNA; Complementary DNA, deoxyribonucleic acid; CNS; Central nervous system; CP; Chlorpyrifos; CPO; Chlorpyrifos-oxon; CPR; Cytochrome p450 reductase; CYP; Cytochrome P450; EE
Keywords: Ach; acetylcholine; ADHD; attention-deficit hyperactivity disorder; BDNF; brain-derived neurotrophic factor; BEND; beta-endorphin; BFNA; beta-funaltrexamine; Ca(2+); calcium; CAMK; calmodulin-dependent protein kinase II; cAMP; cyclic adenosine monophospha
Keywords: Manganese neurotoxicity; Stem cell; Neurodegeneration; Mitochondria; Excitotoxicity; Astrocyte; Oxidative stress; ACTH; adrenocorticotropin hormone; AD; Alzheimer's disease; BDNF; brain-derived neurotrophic factor; CDTA; 1,2-cyclohexylenedinitrilotetraace
Keywords: Triclosan; Mast cell; Mitochondria; Super-resolution microscopy; RBL-2H3; NIH-3T3; Keratinocyte; Ca2+; Fluorescence photoactivation localization microscopy (FPALM); Reactive oxygen species; Membrane potential; Degranulation; Microtubules; Ag; antigen; ATP
Keywords: ACC; acetyl-CoA carboxylase; ACE; angiotensin-converting enzyme; AICAR; 5-aminoimidazole-4-carboxamide ribonucleotide; ALDH2; aldehyde dehydrogenase 2; AMPK; 5' AMP-activated protein kinase; ATP; adenosine triphosphate; Bax; Bcl-2-like protein 4; BNIP3; B
Keywords: WT; wild-type; KO; knockout; tau-/-; homozygous tau KO; mPTP; Mitochondrial permeability transition pore; AD; Alzheimer's disease; GR; Glucocorticoid Receptor; HO; heme oxygenase; GCS; γ-glutamine cysteine synthase; ROS; reactive oxygen species; Mfn1; Mi
Keywords: CsA; cyclosporin A; CV; cyclic voltammetry; DOX; doxorubicin; DPV; differential pulse voltammetry; ETC; electron transport chain; GSH; reduced glutathione; H2O2; hydrogen peroxide; mPTP; mitochondrial permeability transition pore; OXPHOS; oxidative phosph
Keywords: AA; amino acid; Aβo; oligomeric β-amyloid; Aβ; β-amyloid; AD; Alzheimer's disease; α7nAChR; α7 nicotinic acetylcholine receptor; ALS; amyotrophic lateral sclerosis; APLP1; amyloid beta precursor-like protein 1; APP; amyloid precursor protein; β-A
Keywords: Aβ; amyloid β peptide; AD; Alzheimerʹs Disease; ALS; amyotrophic lateral sclerosis; Amb; Amphotericin B; BBB; blood-brain barrier; CJD; Creutzfeld Jakob disease; CSF; cerebral spinal fluid; DCS; D-Cycloserine; DOX; Doxorubicin; GA; Geldanamycin; GAPDH;
Keywords: 6-OHDA; 6-hydroxydopamine; CA; catecholamine; CaMKII; Ca2+/calmodulin-dependent protein kinase II; CDK; cyclin-dependent kinase; CNS; central nervous system; DA; dopamine; ENS; enteric nervous system; ERK; extracellular signal regulated kinase; GI; gastro
Keywords: Parkinson's disease; Ketamine; Subanesthestic-dosage; MPTP; Autophagy;
Keywords: mPTP; mitochondrial permeability transition pore; ROS; reactive oxygen species; CsA; cyclosporine A; CRC; calcium retention capacity; VLeak; mitochondrial leak respiration; VADP; mitochondrial ADP-stimulated phosphorylating respiration; VAtr; mitochondria
Keywords: DA; dopamine; i.c.v; intra-cerebro-ventricular; l-dopa; levodopa; MPTP; 1 méthyl-4-phenyl-1,2,3,6 terahydropyridine; 6-OHDA; 6-hydroxydopamine; PD; Parkinson's disease; SMBS; sodium metabisulfite; SNpc; substantia nigra pars compacta; Parkinson's disease
Keywords: BV; bee venom; BVA; bee venom acupuncture; BVT; bee venom therapy; MPTP; 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine; PD; Parkinson's disease; SN; substantia Nigra; UPDRS; United Parkinson's Disease Rating Scale; Complementary therapies; Dopaminergi
Keywords: Estrogen; Subsarcolemmal mitochondria; Intermyofibrillar mitochondria; mPTP; Heart;
Keywords: Growth factor; Neurotrophin; Axon sprouting; Synaptic plasticity; 6-Hydroxydopamine; MPTP; Sigma-1 receptor; Synuclein;
Keywords: 4-PBA; 4-phenylbutyric acid; ARA; arachidonic acid; ATF6; activating transcription factor 6; BiP or Grp78; 78-kDa glucose regulated protein; COX; cyclooxygenase; CYP; cytochrome P450; DHA; docosahexaenoic acid; eIF2α; eukaryotic translation initiation fa
Keywords: ADP; adenosine diphosphate; ANT; adenine nucleotide translocator; ATP; adenosine triphosphate; Bax; BCL2-associated X protein; Bcl-xL; B-cell lymphoma-extra large; CLP; cecal ligation and puncture; CyP; cyclophilin; DAMP; damage-associated molecular patte
Keywords: Baicalin; Baicalein; Flavonoids; Chemoprevention; Inflammatory diseases; 6-OHDA; 6-hydroxydopamine; 12-LOX; 12-lipoxygenase; AIDS; acquired immunodeficiency disorder syndrome; AhR; aryl hydrocarbon receptor; AIH; autoimmune hepatitis; AICAR; 5-aminoimidaz
Keywords: BBB; blood-brain barrier; CSF; cerebral spinal fluid; COX1; cyclo-oxygenase 1; COX2; cyclo-oxygenase 2; CRP; C reactive protein; DA; dopamine; EGF; Epidermal growth factor; FACIT; functional assessment of chronic illness therapy; FcγRII; Fc gamma recepto
Keywords: 3-HK; 3-hydroxykynurenine; 6-OHDA; 6-hydroxydopamine; A; Amygdala; ACMSD; 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase; AD; Alzheimer's disease; AD; Anterodorsal nucleus (Thalamus); α-syn; Alpha-synuclein; CCL2; Chemokine (CC motif) ligand 2;
Keywords: â¢OH; hydroxyl radical; 2,2-BP; 2,2-bipyridyl; ABC; ATP-binding cassette; AIF; apoptosis-inducing factor; AMPK; AMP-activated protein kinase; AMPKK; AMPK kinase; ANT; adenine nucleotide translocase; AP-1; activator protein 1; Apaf-1; protease activating
Keywords: Dopamine; Ecstasy; Methamphetamine; METH; 3,4-Methylenedioxymethamphetamine; MDMA; Mouse; Neurodegeneration; Neuroinflammation neurotoxicity; Non-human primate; Rat; AC; adenylyl cyclase; AcbSh; nucleus accumbens shell; AcbC; nucleus accumbens core; cAMP;
Keywords: 4-HNE; 4-hydroxy-2-nonenal; 6-OHDA; 6-hydroxydopamine; BSO; buthioninesulfoximine; DFO; Deferoxamine; DMT1; divalent metal transporter 1; ELISA; enzyme-linked immunosorbent assay; FPN1; Ferroportin 1; IRE; iron responsive element; IRP; iron regulatory pro
Keywords: AD; Alzheimer's disease; ADF; alternate day fasting; ALS; amyotrophic lateral sclerosis; APP; β-amyloid precursor protein; BDNF; brain-derived neurotrophic factor; CER; continuous energy restriction; CR; caloric restriction; CREB; cyclic AMP response e
Keywords: α-syn; α-synuclein; AD; Alzheimer's Disease; Al; aluminum; C. elegans; Caenorhabditis elegans; CPF; chlorpyrifos; DA; dopamine; DDE; dichlorodiphenyldichloroethylene; DDT; dichlorodiphenyltrichloroethane; ETC; electron transport chain; FAO; fatty acid